Stargardt Disease vs Age-Related Macular Degeneration: Key Differences

Last updated: 27 October 2026 | Author: Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience

Stargardt disease and age-related macular degeneration (AMD) both damage the macula, the central part of the retina used for reading, recognising faces and fine detail. Because the symptoms sound alike, they are sometimes confused. But the two conditions differ in who they affect, why they happen and how they are managed. Knowing the difference helps you avoid advice that is meant for the other condition.

Quick Comparison

Stargardt disease Age-related macular degeneration
Typical onset Childhood, teens or young adulthood (occasionally later) Usually after age 50
Cause Inherited, most often changes in the ABCA4 gene Ageing plus genetic and lifestyle risk factors such as smoking
Inheritance Usually autosomal recessive Multifactorial; family history raises risk
What is seen Yellow-white flecks and macular atrophy Drusen, geographic atrophy (dry) or abnormal blood vessels (wet)
Central vision Progressive loss; side vision usually preserved Progressive loss; side vision usually preserved
Established treatment No approved cure; supportive care and research trials Anti-VEGF injections for wet AMD; AREDS2 supplements for some with intermediate dry AMD

About Stargardt Disease

Stargardt disease, also called Stargardt macular dystrophy or juvenile macular degeneration, is the most common inherited macular dystrophy. A faulty transporter protein allows waste material (lipofuscin) to build up in the retinal pigment epithelium, which gradually damages the photoreceptors in the macula. Many patients first notice difficulty reading or a grey patch in the middle of vision. Because it begins young, the impact on school, work and independence can be significant. To learn about treatment in India, see our article on macular dystrophy treatment in India.

About AMD

  • Dry AMD (most common): slow thinning of the macula with drusen deposits.
  • Wet AMD: abnormal vessels leak fluid or blood and can cause rapid vision loss; it needs prompt treatment.
  • Risk factors include age, smoking, family history, high blood pressure and cardiovascular disease.

Tests That Tell Them Apart

Test Stargardt disease AMD
Fundus examination Flecks around the macula Drusen, pigment changes
Fundus autofluorescence Characteristic bright and dark patterns Patches of atrophy in later dry AMD
OCT Thinning and loss of outer retinal layers Drusen, fluid or atrophy, depending on type
Fluorescein angiography May show a “dark choroid” in many patients Leakage in wet AMD
Genetic testing Confirms the gene change, often ABCA4 Not routinely required
ERG Helps judge how widespread the disease is Rarely needed

Management Compared

Stargardt disease: There is currently no approved treatment that stops the disease, so care focuses on protecting remaining vision and using it well: UV-protective sunglasses, low-vision aids, regular monitoring and genetic counselling. Many specialists advise avoiding high-dose vitamin A supplements in Stargardt disease, because vitamin A can add to waste build-up. Always ask your retina specialist before taking supplements. Several approaches, including gene, cell and drug-based therapies, are being studied in clinical trials.

AMD: Wet AMD is treated with anti-VEGF injections to stop abnormal vessels. For intermediate dry AMD, certain AREDS2 formulas can reduce the risk of progression. Advice that benefits AMD patients, such as AREDS2 vitamins, is not necessarily right for Stargardt disease, which is why a correct diagnosis matters.

Protecting Your Vision Day to Day

  • Wear sunglasses with UV protection outdoors.
  • Use bright, even lighting and high-contrast materials at home.
  • Try magnifiers, screen readers and large-print settings.
  • Do not smoke, as it speeds AMD and is harmful to eye health in general.
  • Attend regular follow-ups so changes are caught early.

Ask Our Team a Question

Frequently Asked Questions

Is Stargardt disease the same as macular degeneration?

It is a form of inherited macular degeneration that starts early in life. It is different from age-related macular degeneration.

Can Stargardt disease lead to total blindness?

It usually affects central vision and leaves side vision intact, so people typically keep the ability to move around independently.

Do vitamins help Stargardt disease?

Do not self-prescribe. High-dose vitamin A is usually discouraged; discuss any supplement with your retina specialist.

Can AMD be inherited?

Genes contribute to AMD risk, but it does not follow a simple pattern like Stargardt disease.

Can children have AMD?

No. Central vision loss in a child or teenager points to a macular dystrophy such as Stargardt disease, not AMD.

Is there any treatment on the horizon for Stargardt disease?

Gene therapy, cell therapy and small-molecule drugs are in clinical trials. You can search them on ClinicalTrials.gov.

Official References

Disclaimer: This article is for education and does not replace advice from a retina specialist.
Scroll to Top
Call Now Button